By Deena Beasley (Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them ...

Doctors suggest that anybody with a Body mass index of over 30 or greater than 27 is advised to try weight loss drugs.

To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Medicare covers weight loss drugs including Ozempic under specific conditions when the drug also has potential use cases beyond weight loss.

Paxton's office said the company supplied free nurses to help care for patients who received its drugs, as well as ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster ...

Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo ...

Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says By Jen Christensen, CNN, CNNWire Wednesday, April 17, 2024 ...